Story
Orexo Reports Wider Q2 Loss as Revenue Misses Estimates
Orexo AB reported a wider net loss for the second quarter, with revenue that missed consensus estimates. The Swedish specialty pharmaceutical company said earnings per share came in at -SEK 2.92, as it navigates a period of increased investment and strategic changes.
Key Financials
The company's performance was marked by a significant top-line miss. Key figures from the report include:
- Revenue: SEK 3.50 million, well below the consensus analyst estimate of SEK 5 million.
- EBIT: A loss of -SEK 103.30 million.
- EBITDA: A loss of -SEK 95.10 million.
Orexo attributed the negative results to a year-over-year decline in revenue and a rise in operating expenses. The company cited continued spending on research and development as well as organizational adjustments following the divestment of its Zubsolv asset in the United States.
Pipeline and Future Outlook
AdDespite the quarterly loss, Orexo highlighted progress in its development pipeline. The company noted growing external interest in its AmorphOX drug delivery platform and confirmed it is in multiple partnering discussions.
Looking ahead, Orexo plans to resubmit its New Drug Application (NDA) for Izipry in the third quarter of 2026, with potential FDA approval anticipated in the first quarter of 2027. Additionally, a pivotal trial for its OX640 candidate is scheduled to begin in the fourth quarter of 2026, with results expected in the first quarter of 2027.
Financing and Legal Challenges
Orexo also stated that it is evaluating opportunities for additional financing. The company said the funds would be used to support its growth initiatives and to resolve ongoing legal matters related to the U.S. Department of Justice. This introduces a key variable for investors monitoring the company's capital structure and legal risks.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.